Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Alnylam Pharmaceuticals, Inc.

NASDAQ: ALNY · Life Sciences · 6 alerts · CIK 1178670

Share price
$159.73Close, Nov 16
Market cap
$21.4B
Shares outstanding
133.94MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Alnylam Pharmaceuticals, Inc. filings on SEC EDGAR ↗

7:37 AM ET 8-K
Stock Buyback

Alnylam Pharmaceuticals Announces $1B Stock Buyback

Alnylam Pharmaceuticals announced that its Board of Directors authorized a new $1.0 billion share repurchase program. The company expects to repurchase approximately $500 million of its common stock by the end of 2026, with the remaining balance planned for 2027. Additionally, the company disclosed that Tolga Tanguler will depart from his role as Executive Vice President and Chief Commercialization Officer in December 2026.

Value
$1B

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.